The bill, known as the Old Drugs, New Cures Act, seeks to change how certain drugs are treated under Medicare and Medicaid programs in the United States. It introduces the designation of "priority research drugs" for drugs that have been on the market for at least 10 years...
Simple Explanation
The bill is about making sure certain old medicines, which are being studied for new uses, don't get labeled as "extra versions" of existing medicines, so drug companies might get more money when selling them to Medicare and Medicaid. But figuring out which medicines get this special label might be tricky and could make things more expensive.